Content about Myocardial infarction

June 6, 2013
Study: Aspirin may be effective for reducing cancer deaths

Recent data suggests that aspirin may be effective for reducing cancer deaths in addition to preventing heart attacks, raising the question whether the combined health benefits outweigh the risks of gastrointestinal bleeding and stroke for middle-aged men, researchers announced Wednesday.

CHAPEL HILL, N.C. — Recent data suggests that aspirin may be effective for reducing cancer deaths in addition to preventing heart attacks, raising the question whether the combined health benefits outweigh the risks of gastrointestinal bleeding and stroke for middle-aged men, researchers announced Wednesday.

January 29, 2013
Wills Eye Institute: Incidence linking aspirin to macular degeneration too low to stop aspirin therapy

"Talk to your cardiologist." That's the advice offered last week by Wills Eye Institute, a hospital specializing in eye care, following a JAMA article linking aspirin therapy to macular degeneration.

PHILADELPHIA — "Talk to your cardiologist." That's the advice offered Friday by Wills Eye Institute, a hospital specializing in eye care,  following a JAMA article linking aspirin therapy to macular degeneration. 

July 31, 2012
MinuteClinic, American Heart Association collaborate for hypertension management

CVS Caremark’s MinuteClinic has teamed up with the American Heart Association in a nationwide effort to improve the identification, treatment and management of high blood pressure.

WOONSOCKET, R.I. — CVS Caremark’s MinuteClinic has teamed up with the American Heart Association in a nationwide effort to improve the identification, treatment and management of high blood pressure.

According to the American Heart Association, 1-out-of-3 American adults has high blood pressure or hypertension. Uncontrolled high blood pressure can lead to stroke, heart attack, heart failure and kidney failure.

June 21, 2012
RxAlly launches blood-pressure education campaign

RxAlly has created a new campaign that is designed to support the Million Hearts initiative.

LEESBURG, Va. — RxAlly has created a new campaign that is designed to support the Million Hearts initiative.

March 23, 2012
An aspirin a day to keep the oncologist away

Evidence supporting the daily use of aspirin to help prevent and possibly treat cancer was published Tuesday in a collection of three papers — two in The Lancet and one in Lancet Oncology.

LONDON — Evidence supporting the daily use of aspirin to help prevent and possibly treat cancer was published Tuesday in a collection of three papers — two in The Lancet and one in Lancet Oncology.

December 20, 2011
Study: High blood pressure in middle age fair predictor of heart attack, stroke

A hike in blood pressure during middle age significantly raises the risk of having a heart attack or a stroke, according to new Northwestern Medicine research released Monday.

CHICAGO — A hike in blood pressure during middle age significantly raises the risk of having a heart attack or a stroke, according to new Northwestern Medicine research released Monday. The study offers a new understanding on the importance of maintaining low blood pressure early in middle age to prevent heart disease later in life.

December 7, 2011
Despite bleeding risk, aspirin may be beneficial before cardiac surgery

Aspirin taken within five days before cardiac surgery is associated with a significant decrease in the risk of major postoperative complications, including renal failure, an intensive care unit stay, and even early death (30-day mortality), according to findings from an observational cohort study by researchers at Thomas Jefferson University and the University of California Davis Medical Center that are set to appear in the journal Annals of Surgery.

PHILADELPHIA — Aspirin taken within five days before cardiac surgery is associated with a significant decrease in the risk of major postoperative complications, including renal failure, an intensive care unit stay, and even early death (30-day mortality), according to findings from an observational cohort study by researchers at Thomas Jefferson University and the University of California Davis Medical Center that are set to appear in the journal Annals of Surgery.

October 14, 2011
CDC: Reductions in heart disease rates vary by geography, race, ethnicity

Despite declines in the number of Americans reporting coronary heart disease, rates vary widely between states and between racial and ethnic groups, according to a new study by the Centers for Disease Control and Prevention.

ATLANTA — Despite declines in the number of Americans reporting coronary heart disease, rates vary widely between states and between racial and ethnic groups, according to a new study by the Centers for Disease Control and Prevention.

August 16, 2011
Study: Effient reduces cardiovascular risk among younger, heavier patient cohort

A special group of patients who participated in a trial of a heart disease drug made by Daiichi Sankyo and Eli Lilly showed fewer heart attacks, strokes and deaths related to cardiovascular disease than patients taking a competing drug, according to an analysis of study results.

INDIANAPOLIS — A special group of patients who participated in a trial of a heart disease drug made by Daiichi Sankyo and Eli Lilly showed fewer heart attacks, strokes and deaths related to cardiovascular disease than patients taking a competing drug, according to an analysis of study results.

July 21, 2011
Brilinta receives FDA approval

The Food and Drug Administration has approved a drug made by AstraZeneca to reduce the rate of heart attacks in patients with acute coronary syndrome, the Anglo-Swedish drug maker said.

WILMINGTON, Del. — The Food and Drug Administration has approved a drug made by AstraZeneca to reduce the rate of heart attacks in patients with acute coronary syndrome, the Anglo-Swedish drug maker said.

AstraZeneca announced the approval of Brilinta (ticagrelor), a blood-thinning drug, on Wednesday. The drug maker is touting the drug as an alternative to Plavix (clopidogrel), made by Sanofi and Bristol-Myers Squibb.

July 20, 2011
Forgoing daily aspirin regimen boosts heart attack risk, study finds

A new study published in the July 19 online edition of BMJ found that heart disease patients that opt out of taking low-dose aspirin daily put themselves at a higher risk for heart attack.

NEW YORK — A new study published in the July 19 online edition of BMJ found that heart disease patients that opt out of taking low-dose aspirin daily put themselves at a higher risk for heart attack.

February 17, 2011
APhA encourages consumers to consult pharmacists about heart health

February is American Heart Month, and a professional group representing the country’s pharmacists is using that as an opportunity to encourage the public to learn how to prevent heart disease from the most easily accessible members of the healthcare system.

WASHINGTON — February is American Heart Month, and a professional group representing the country’s pharmacists is using that as an opportunity to encourage the public to learn how to prevent heart disease from the most easily accessible members of the healthcare system.

February 14, 2011
Study: Bristol's apixaban effective among atrial fibrillation patients

An investigational drug made by Bristol-Myers Squibb works better than aspirin in reducing the risk of complications in certain patients with heart rhythm problems, according to results of a late-stage clinical trial published in the New England Journal of Medicine.

NEW YORK — An investigational drug made by Bristol-Myers Squibb works better than aspirin in reducing the risk of complications in certain patients with heart rhythm problems, according to results of a late-stage clinical trial published in the New England Journal of Medicine.

Bristol said results of the phase-3 study comparing apixaban with aspirin showed that in patients with atrial fibrillation who were not suited to take the drug warfarin, apixaban was more effective than aspirin in reducing stroke and systemic embolism.

January 10, 2011
Aspirinpod gets to heart of matter

Aspirinpod recently launched its Aspirinpod emergency aspirin container — a small heart-shaped container that can be carried on a key chain.

DALLAS — Aspirinpod recently launched its Aspirinpod emergency aspirin container — a small heart-shaped container that can be carried on a key chain.

Aspirinpod is a reminder to have aspirin with you at all times in the event of a heart attack, noted company founder Patti Frenette.

The small container, which does not include the aspirin, is large enough for two 325-mg tablets or four 81-mg tablets. Suggested retail price is $2.99.

November 21, 2010
Vytorin helps reduce cardiac events in chronic kidney disease patients

A cholesterol-lowering drug made by Merck appears to reduce the risk of heart attacks, strokes...

DENVER A cholesterol-lowering drug made by Merck appears to reduce the risk of heart attacks, strokes and cardiac death in patients with chronic kidney disease, according to results of a new study.

 

Merck said results of a 9,000-patient clinical study showed that Vytorin (ezetimibe and simvastatin) reduced the risks by 16.1% compared with placebo. Results of the study were presented Saturday at the annual meeting of the American Society of Nephrology.

 

 

October 6, 2010
Joy and Eve Behar join heart disease awareness campaign

Bayer Consumer Care and WomenHeart: The National Coalition for Women with Heart Disease on Wednesday...

June 3, 2010
Low-dose aspirin recommendations revised for younger diabetic patients

Findings published in the online edition of Diabetes Care have indicated that diabetics under a...

March 14, 2010
Study: Combined lipid, blood pressure therapies don’t reduce diabetes patients’ cardiovascular risk

Diabetes patients combining drugs to control blood fat and blood pressure may remain at risk...

NEW YORK Diabetes patients combining drugs to control blood fat and blood pressure may remain at risk for heart attacks and other heart disease, according to a study presented in Atlanta on Sunday.

March 11, 2010
Bayer aspirin quick release crystals

CVS had this citrus-flavored Bayer aspirin quick release crystals clip-stripped within adult dentures. And while...

CVS had this citrus-flavored Bayer aspirin quick release crystals clip-stripped within adult dentures. And while this product isn’t the 81 mg of aspirin recommended for daily consumption to prevent a second heart attack (it contains 850 mg in each powder pouch), there is still a very strong need for this kind of easily stored/quickly administered aspirin product for seniors.

January 24, 2010
Rite Aid supports 'Go Red For Women' with heart health guide

Rite Aid on Monday announced that it again is supporting the American Heart Association’s "Go...

January 11, 2010
Bayer with an easy-to-open cap

Bayer has introduced its own easy grip cap for arthritis users, diabetics or people with...

NEW YORK Bayer has introduced its own easy grip cap for arthritis users, diabetics or people with carpal tunnel.

And with the low-dose 81-mg aspirin for the prevention of a second heart attack or stroke, disease states that still skew older than younger, the new caps ought to be well received among Bayer's low-dose aspirin core users.